Treatment by combined chemotherapy for recurrent ovarian cancer
Shershah, S.
JPMA. Journal of the Pakistan Medical Association 35(11): 341-343
1985
ISSN/ISBN: 0030-9982 PMID: 3935821 Document Number: 255745
Document emailed within 1 workday
Related Documents
Inagaki, J.; Ogawa, M.; Horikoshi, N.; Ezaki, K.; Inoue, K.; Aiba, K.; Komyo, M.; Miyamoto, H.; Ikeda, K.; Kubo, H. 1983: Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1291-1295Giseĭnov, K.D.; Beliaev, A.M.; Senchik, K.I.; Maksimov, S.I.; Urmancheeva, A.F.; Gafton, G.I.; Mikaia, N.A.; Beliaeva, O.A.; Kireeva, G.S.; Gorodnova, T.V.; Matveeva, N.S. 2014: Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer Voprosy Onkologii 60(3): 343-347
Sunagozaka, H.; Yamashita, T.; Kagaya, T.; Kato, Y.; Kaneko, S. 2006: A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 829-832
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Wydra, D.; Emerich, J. 2002: Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer Ginekologia Polska 73(11): 1044-1047
Satthapong, D.; Tangjitgamol, S.; Manusirivithaya, S.; Pataradool, K. 2007: Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer Journal of the Medical Association of Thailand 90(3): 411-419
Gorbunova, V.A.; Perevodchikova, N.I.; Kozachenko, V.P.; Ryzhakov, V.M.; Marenich, A.F.; Zhordania, K.I. 1991: The potentials of combined chemotherapy in disseminated ovarian cancer Akusherstvo i Ginekologiia 2: 54-57
Sugimori, H.; Kidera, Y.; Matsuyama, T. 1982: Combined chemotherapy of ovarian cancer with special reference to carboquone Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(1): 66-71
Bliumenberg, A.G.; Gorbacheva, L.B.; Gorbunova, V.A.; Kozachenko, V.P.; Lankin, V.Z. 1996: Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives Biulleten' Eksperimental'noi Biologii i Meditsiny 122(12): 651-654
Tropé, C.; Kristensen, G.; Kisic, J.; Kaern, J. 2001: Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer European Journal of Gynaecological Oncology 22(3): 223-227
Shimoyama, S.; Kondo, K.; Kataoka, M.; Kinoshita, M.; Yamamura, K.; Kei, F.; Ohshima, Y.; Chin, K.; Hatsuno, T.; Kajikawa, M.; Miura, K.; Horisawa, M. 2004: A case of recurrent advanced gastric cancer with lung metastasis effectively treated by combined chemotherapy of TS-1 and weekly CDDP Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(1): 103-105
Robová, H.; Rob, L.; Pluta, M.; Halaska, M.; Chmel, R. 2009: Treatment of recurrent ovarian cancer Ceska Gynekologie 74(6): 464-468
Kitao, A.; Matsumoto, K. 2012: Treatment of recurrent ovarian cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 628-633
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Lehoczky, O.ó 2005: Neoadjuvant chemotherapy in the treatment of ovarian cancer Orvosi Hetilap 146(38): 1951-1955
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
Palamarchuk, I.D. 1992: Combined treatment of recurrent lung cancer Klinicheskaia Khirurgiia 5: 34-36
Akers, S.N.; Riebandt, G.; Miller, A.; Groman, A.; Odunsi, K.; Lele, S. 2013: Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study European Journal of Gynaecological Oncology 34(2): 113-119